[Federal Register Volume 62, Number 96 (Monday, May 19, 1997)]
[Notices]
[Page 27262]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-13021]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration
[Docket No. 96N-0192]


Agency Information Collection Activities; Announcement of OMB 
Approval

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Application to Market a New Drug, 
Biologic, or an Antibiotic Drug for Human Use; Use of Form FDA 356h'' 
has been approved by the Office of Management and Budget (OMB) under 
the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Margaret R. Wolff, Office of 
Information Resources Management (HFA-250), Food and Drug 
Administration, 5600 Fishers Lane, rm. 16B-19, Rockville, MD 20857, 
301-827-1223.

SUPPLEMENTARY INFORMATION: In the Federal Register of March 13, 1997 
(62 FR 11899), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 
section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). 
OMB has now approved the information collection and has assigned OMB 
control number 0910-0338. The approval expires on April 30, 2000. An 
agency may not conduct or sponsor, and a person is not required to 
respond to, a collection of information unless it displays a currently 
valid OMB control number.

    Dated: May 13, 1997.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 97-13021 Filed 5-16-97; 8:45 am]
BILLING CODE 4160-01-F